Skip to main content
Robert Kalayjian, MD, Infectious Disease, Cleveland, OH, MetroHealth Medical Center

RobertCKalayjianMD

Infectious Disease Cleveland, OH

Associate Professor, Medicine, Case Western Reserve University School of Medicine

Dr. Kalayjian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kalayjian's full profile

Already have an account?

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1988 - 1990
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1982 - 1985
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1982

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1988 - 2024
  • TN State Medical License
    TN State Medical License 1985 - 1988
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults with Human Immunodeficiency Virus...  
    C William Wester, Edgar Turner Overton, Susan L Koletar, Kristine M Erlandson, Constance A Benson, Robert C Kalayjian, Clinical Infectious Diseases

Press Mentions

  • Why Humans Are Making Epidemics Worse
    Why Humans Are Making Epidemics WorseMarch 29th, 2016

Grant Support

  • ACTG A5146: Therapeutic Drug Monitoring On Viral Load, Pi-Experienced HIV-1 PTSNational Center For Research Resources2006
  • A5223: Sex Differences In Lpv/Rtv In HIV Infected Men And WomenNational Center For Research Resources2006
  • A5214: SQ Single Dose Interleukin-7 In HIV-1 Infected SubjectsNational Center For Research Resources2006
  • A5163: Weekly Alendronate In HIV Subjects With Decreased Bone Mineral DensityNational Center For Research Resources2006
  • A5142:Comparison Of Treatment For Initial Therapy Of HIV InfectionNational Center For Research Resources2006
  • A5211: An Orally Administered HIV-1 Entry Inhibitor In HIV Tx Experienced PTSNational Center For Research Resources2005–2006
  • ACTG A5177:Pharmacokinetics Of Efavirenz, Nevirapine, Lopinavir/Ritonavir In HIVNational Center For Research Resources2005
  • ACTG A5163:Qweek Alendronate In HIV Subjects With Decreased Bone Mineral DensityNational Center For Research Resources2005
  • ACTG A5142:Comparison Of Treatment For Initial Therapy Of HIV InfectionNational Center For Research Resources2005
  • ACTG A5163: Weekly Alendronate In HIV Subjs With Decreased Bone Mineral DensityNational Center For Research Resources2004
  • ACTG A5148: Niacin For Treatment Of Elevated Non-Hdl Cholesterol In HIVNational Center For Research Resources2004
  • ACTG A5143/A5147s: Dual VS Triple PI Combinations For Treatment Failures In HIV1National Center For Research Resources2004
  • ACTG A5142-Comparison Of Treatment For Initial Therapy Of HIV InfectionNational Center For Research Resources2004
  • ACTG A5110-Thymidine Analogue Substitution Or Nucleoside-Sparing RegimenNational Center For Research Resources2004
  • ACTG 384--Protease /Reverse Transcriptase Inhib In HIVNational Center For Research Resources2000–2002
  • ACTG 349--Immunologic &Virologic Effects Of Prednisone On HIV-1 InfectionNational Center For Research Resources2000–2002
  • Abt378/Ritonavir/Stavudine/Lamivudine/Nelfinavir In HIV InfectionNational Center For Research Resources2000–2002
  • Abt378/Ritonavir In Combination With Other Drugs In HIV InfectionNational Center For Research Resources2000–2002
  • Antituberculosis Agents In HIV Infected Persons W/ TBNational Center For Research Resources1999–2002
  • Viral Activation Transfusion Study (VATS)National Center For Research Resources1997–2002
  • ACTG 372:Prolongation Of Virologic Success &Options For Failure In HNational Center For Research Resources1999–2000
  • ACTG 370:Virologic &Immunologic Activity Of Continued Lamivudine VSNational Center For Research Resources1999–2000
  • ACTG 359:Soft Gelatin Capsule Of Saquinavir W/ Ritonavir Or NelfinaviNational Center For Research Resources1999–2000
  • ACTG 271--Prednisone Therapy In HIV Associated NephropathyNational Center For Research Resources1996–1997
  • Foscarnet Cream For The Treatment Of Mucotaneous Herpes SimplexNational Center For Research Resources1996
  • Foscarnet Cream For The Treatment Of Mucocutaneous Herpes SimplexNational Center For Research Resources1995

Hospital Affiliations